ERBB2 and metastatic malignant neoplasm in the lymph nodes: Other factors such as gender, age, ECOG PS, peritoneum metastasis, liver metastasis, lung metastasis, lymph node metastasis, metastasis sites, treatment lines, and HER-2 status were not significantly different (P>0.05; Table 1).